Results 281 to 284 of about 152,115 (284)

A Phase 3 Trial of Bevacizumab in Ovarian Cancer

New England Journal of Medicine, 2011
Timothy J Perren, Jonathan A Ledermann, Gunnar B Kristensen   +2 more
exaly  

Bevacizumab

Reactions Weekly
openaire   +1 more source

Bevacizumab

Reactions Weekly, 2006
openaire   +1 more source

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial

Ca-A Cancer Journal for Clinicians
exaly